Uk Smes Should Be Given Access To University Ip To …

FX_Headlines_Euro-Zone_CPI_UK_Jobs_Data_Offer_Little_to_Help_Euro_Pound_body_x0000_i1028.png, FX Headlines: Euro-Zone CPI, UK Jobs Data Offer Little to Help Euro, Pound

Markets closed FX Headlines: Euro-Zone CPI, UK Jobs Data Offer Little to Help Euro, Pound By Christopher Vecchio | DailyFX 13 hours ago – Euro-Zone inflation remains absent in September; doesnt mean another LTRO. – Lackluster UK wage growth undercuts otherwise stronger labor market report. – Best Swiss ZEW survey since May 2010. To keep up with the European data and news as the week goes forward, be sure to sign up for my distribution list . EURO-ZONE ECONOMIC CALENDAR The September inflation figures paint a dim picture on the yearly side but the monthly figure would suggest that growth may be on the mend. Taking the CPI figures in context of the October German ZEW survey figures, released yesterday, it is clear that: 1) Euro-Zone growth momentum slowed midyear; and 2) growth may show signs of slight continued improvement through the 4Q13. The Euro was mostly unchanged on the headline versus its major counterparts, and with no more significant economic due this week, the influence of US fiscal headlines on the Euro will likely uncrease. Jobs growth accelerated and jobless claims the unemployed receiving financial assistance plunged at the end of the 3Q13. While the data initially sparked a rally in the British Pound , the secondary but still important data wages prevented an upside momentum developing from the start. Wage growth undershot estimates for August and considering that over 60% of the UK economy is consumption-based, a further stagnation in wages will ultimately hurt UK growth. In the broader context of the labor, demand is increasing which should support wages going forward; and the UK services sector just had its best quarter in 16 years in the 3Q13, which should also prove supportive of wages down the line.

New UK autism cases level off after five-fold surge in 1990s

Autism-Aspergers Awareness Ribbon

“The payback is that universities could get a one or two per cent shareholding on the basis that some of these companies will become the next generation of ARMs and CSRs. There is growing support for these ideas and it is already happening in a number of UK universities.” Professor Hopper has co-founded a dozen spin-outs and start-ups, including Virata, a global chip company and more recently RealVNC and Ubisense. Hopper also collaborated with Hermann Hauser for his earlier venture at Acorn Computers. His talk last night also argued that the Government is not doing enough to harness the UK’s rich seam of engineering skills and innovation and needs to do more to encourage young people to follow careers in science and technology. Professor William Webb, CEO of the Weightless SIG and Cambridge Wireless Board member said, “It was a pleasure and inspiration to hear Professor Hopper present his views on a topic that is imperative to the wireless industry characterised by the growing number of companies that make up the Cambridge cluster. There is so much potential in university IP that it is only logical that the companies best placed to exploit and develop it should be granted easy access.” The Prestigious Lectures Series has been specially designed and created for Cambridge Wireless Founder Members and is chaired by Professor William Webb. The Andy Hopper lecture was sponsored by Rohde & Schwarz. For more information please visit www.cambridgewireless.co.uk or follow on Twitter – #CWLecture About Cambridge Wireles Cambridge Wireless is a leading industry forum and vibrant community with a rapidly expanding network of companies actively involved in the development and application of wireless technologies. In addition to high level networking dinners and events, a strong educational programme and business development activities, Cambridge Wireless runs the annual Future of Wireless International Conference along with the prestigious Discovering Start-Ups programme and competition to support emerging, innovative wireless companies. Sixteen Special Interest Groups focused on specific technologies and market sectors, also provide opportunities for members to meet, form partnerships to exploit new commercial opportunities, and share knowledge and information about the latest industry trends and hot topics. Cambridge Wireless has partnerships with other leading industry clusters and organisations around the world to extend its international reach and to keep members up to date with the latest global developments and business opportunities. For more information, please visit www.cambridgewireless.co.uk For more information, please contact: Lily Cheng Cambridge Wireless – 01223 422365, lily.cheng@cambridgewireless.co.uk Peter Rennison or Allie Andrews PRPR – 01442 245030, pr@prpr.co.uk / allie@prpr.co.uk ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web.

Contact Center Solutions Interaction Analyzer™

Prompted by these data, which found that one in every 88 eight year old children in the US had been diagnosed with an autistic spectrum disorder in or before 2008, the authors wanted to find out if there were comparable rates in the UK. They used entries into the General Practice Research Database (GPRD), which contains around three million anonymised active patient records from over 300 representative general practices in the UK equivalent to 5% of the UK population. Data from practices enrolled from 1990, when the GPRD was set up, were used to calculate the annual prevalence (number of people living with the condition) and the annual incidence (number of newly diagnosed cases) of autistic spectrum disorders among eight year olds, all of whom were born after 1996. Annual prevalence rates for 2004-2010 were calculated by dividing the number of eight year olds diagnosed as autistic in that or any previous year, by the number of eight year olds enrolled in the database for each year. Annual incidence rates were calculated by dividing the number of eight year olds who had been newly diagnosed with autism between 2004 and 2010 by the number of eight year olds enrolled into the database for each of those years. The results showed that the annual prevalence and incidence of autism did not materially change over the entire study period, for either boys or girls. The annual prevalence of autistic spectrum disorders was estimated at 3.8 per 1000 boys and 0.8 per 1000 girls, while the annual incidence was estimated at 1.2 per 1000 boys (1190 in total) and 0.2 per 1000 girls (217 in total). Girls were about 75% less likely to be diagnosed with an autism spectrum disorder as boys. The UK prevalence of about 4/1000 children is substantially lower than the equivalent US figure of about 11/1000 children in 2008, which was reported in 2012. The large difference between countries is closely similar to differences in rates reported for children diagnosed and treated for attention deficit hyperactivity disorder in the two countries, the authors point out. Autism-Aspergers Awareness Ribbon Their previously published research, based on the same database, showed that the cumulative incidence of autism among children born in UK between 1988 and 1995 increased continuously by a factor of five during that period. And they say that both studies provide compelling evidence that a major rise in incidence rates of autism, recorded in general practice, occurred in the decade of the 1990s but reached a plateau shortly after 2000 and has remained steady through 2010. Similar widespread sharp rises in the number of children diagnosed as autistic were also seen in the 1990s in other parts of Europe and North America, they add, making it unlikely that better understanding of the condition or a broadening of the diagnostic criteria alone could have been responsible for these simultaneous large increases. Given the apparent sudden halt in the rise in rates from early 2000 onwards at least in the UK the actual cause of the dramatic rise in the 1990s remains a mystery, they write, emphasising that the suggestion that it might be linked to the MMR vaccine has been conclusively ruled out.